The pharmaceutical company PharmaMar has reported this Wednesday that it will deliver 128,048 shares to its employees, for a total value of 592,063.61 euros, and up to a maximum amount of 12,000 euros per beneficiary.
Through a communication to the National Securities Market Commission (CNMV), PharmaMar has underlined that the reference value of the share has finally been established at 4.6108 euros, corresponding to the average of the daily weighted average changes in the share. of the pharmaceutical group in the continuous market of the last month.
Once the reference value has been definitively established, the total number of shares to be freely delivered to the beneficiaries has finally been established at 128,048 shares (0.0577% of the share capital).
The shares will be delivered through a change of ownership that is expected to take place soon, once the corresponding accounts have been opened to the beneficiaries of said plan.